Patent · US Expired

Apparatus and method for predicting cardiac arrhythmia by detection of micropotentials and analysis of all ECG segments and intervals

US5609158A · kind A · utility

146Cited by
23References
27Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 1, 1995
Grant dateMar 11, 1997
Priority date
Expiry dateMay 1, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B5/7257
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An apparatus and method for the acquisition and analysis of electrocardiogram signals, to non-invasively detect and quantify presence of abnormal cardiac conduction patterns in patients at risk of heart disease, e.g. ventricular tachycardia; atrial fibrillation and flutter. Signals from the orthogonal X, Y and Z surface leads are amplified, digitized and either stored for later processing, or processed immediately. The incoming beats can either be R wave-triggered, aligned and ensemble-averaged for studies of patients at risk for ventricular pathologies such as ventricular tachycardia, or P wave-triggered, aligned and ensemble-averaged for studies of patients at risk for atrial pathologies, e.g. atrial fibrillation and flutter. QRS onset and offset, and P wave onset and offset, are calculated for ventricular and atrial post-analysis applications, respectively. The windowed Fourier transform of the second derivative (acceleration) of the signal-averaged ECG is calculated for particular regions of interest for each lead, including the intra-QRS, ST-segment, T and P wave regions. A novel Spectral Change Index, calculated from the resulting "acceleration spectrum" for each lead as well…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.